Global and United States Digital Biomanufacturing Market Report & Forecast 2022-2028

Digital Biomanufacturing is dramatically changing the pharmaceutical industry. The connections between devices, materials and people brought by IIoT and data analytics platforms are leading to more efficient and faster processes.
Market Analysis and Insights: Global and United States Digital Biomanufacturing Market
This report focuses on global and United States Digital Biomanufacturing market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Digital Biomanufacturing market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Manufacturing Technologies accounting for % of the Digital Biomanufacturing global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Bioprocess Optimization and Process Analytics was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
A huge amount of data is produced at every step of pharmaceutical manufacturing. Various automated systems at companies and contract manufacturing sites also generate large amounts of information. The resulting non-standard terminology and changing data structures complicate communication systems and delay product releases. Digital Biomanufacturing can solve this problem very well.
Global Digital Biomanufacturing Scope and Market Size
Digital Biomanufacturing market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Digital Biomanufacturing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Digital Biomanufacturing market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Manufacturing Technologies
Analytical and Process Control Technologies
Software
Others
Segment by Application
Bioprocess Optimization and Process Analytics
Biomanufacturing Process Automation and Control
Flexible Manufacturing
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
3M Co.
ABB Group
Agilent Technologies Inc.
Shimadzu Corp.
Thermo Fisher Scientific Inc.
Waters Corp.
AB Sciex LLC
Sartorius Stedium Biotech GmbH
Alertenterprise
GE Healthcare